Acute Breast Abscess
Conditions
Keywords
Acute breast abscess, Percutaneous suction drain, Incision and drainage
Brief summary
This prospective interventional study compares the effectiveness of standard incision and drainage versus percutaneous suction drain placement in the management of acute pyogenic breast abscess. Eighty patients were enrolled and allocated equally into two groups. The study evaluates outcomes including postoperative pain, duration of hospital stay, wound healing time, number of dressings required, complications, and recurrence. The aim is to determine whether percutaneous suction drainage provides superior clinical outcomes compared to conventional surgical management.
Detailed description
Acute breast abscess is a common surgical condition requiring prompt intervention. Conventional incision and drainage (I&D) has been the standard treatment; however, it is associated with increased pain, prolonged healing, and frequent dressings. Minimally invasive techniques such as percutaneous suction drainage (PSD) have emerged as alternatives with potential advantages. This prospective comparative interventional study was conducted at GSVM Medical College, Kanpur, from May 2025 to Feb 2026. Eighty patients diagnosed with acute pyogenic breast abscess were allocated into two groups: Group A (I&D) and Group B (PSD). Outcomes assessed included postoperative pain (VAS score), duration of hospital stay, wound healing time, number of dressings, complications (residual abscess, fistula), and recurrence at 3 months. The study aims to compare the efficacy and safety of both treatment modalities.
Interventions
Standard surgical incision and drainage of breast abscess with evacuation of pus.
Minimally invasive placement of suction catheter for drainage of breast abscess.
Sponsors
Study design
Masking description
This was an open-label study with no blinding of participants or investigators.
Intervention model description
Participants were allocated into two groups: incision and drainage and percutaneous suction drainage using an odd-even allocation method.
Eligibility
Inclusion criteria
* Patients diagnosed with acute pyogenic breast abscess * Abscess size ≥ 3 cm on ultrasonography * Willing to participate and provide written informed consent
Exclusion criteria
* Abscess size \< 3 cm on ultrasonography * Patients unwilling to provide informed consent * Pre-existing skin disorders involving the breast * Significant comorbid conditions (e.g., coagulopathy, diabetes mellitus, HIV infection, hepatitis B or C) * Diagnosed cases of antibioma * Tuberculous mastitis * Breast malignancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative pain | Day 1, 3, 7, 14, 30, 60, and 90 post procedure | Postoperative pain will be assessed using the Visual Analog Scale (VAS), a patient-reported pain assessment scale ranging from 0 to 10, where: 0 = no pain 10 = worst imaginable pain Higher scores indicate greater pain severity. Pain scores will be recorded on postoperative Day 1, Day 3, Day 7, Day 14, Day 30, Day 60, and Day 90 after the procedure. |
| Number of Dressings | Within 30 days post-procedure | Total number of postoperative dressings required per patient in number |
| Length of Hospitalization | Up to 15 days post-procedure | Length of hospital stay measured in days from procedure to discharge |
| Wound healing | From procedure to complete wound healing (up to 30 days) | Time to complete wound healing, defined as the number of days from the procedure to full epithelialization of the wound with absence of discharge, assessed by clinical examination. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Residual Abscess | Within 30 days post-procedure | Incidence of residual abscess, defined as the presence of a persistent or recurrent fluid collection at the original site confirmed by clinical examination and/or ultrasonography after the initial procedure. |
| FISTULA FORMATION | Within 30 days post-procedure | Incidence of fistula formation, defined as the development of a persistent abnormal tract with discharge from the wound site following the procedure, confirmed by clinical examination. |
Countries
India